False-negative testing errors in routine viral marker screening of blood donors

Transfusion

Volumn 40, Issue 5, 2000, Pages 585-589

  Busch, Michael P ^a   Watanabe, K K ^b   Smith, J W ^b   Hermansen, S W ^b   Thomson, R A ^b  

^a Blood Centers of the Pacific   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; SCREENING TEST; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; DATABASES; DELTARETROVIRUS INFECTIONS; FALSE NEGATIVE REACTIONS; HEPATITIS C; HIV INFECTIONS; HUMANS; RISK FACTORS;

EID: 0034081765     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40050585.x     Document Type: Article

References (21)

1. Busch MP, Stramer SL, Kleinman SH. Evolving applications of nucleic acid amplification assays for prevention of viral transmission by blood components and derivatives. In: Garratty G, ed. Applications of molecular biology to blood transfusion medicine. Bethesda: American Association of Blood Banks, 1997:123-76.
2. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
3. Kleinman SH, Busch MP, Korelitz JJ, Schreiber GB. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfus Med Rev 1997;11:155-72.
4. Hjelle B, Wilson C, Cyrus S, et al. Human T-cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors. Blood 1993;81:1641-4.
5. Schable C, Zekeng L, Pau CP, et al. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-4.
6. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992;327:1899-905.
7. Persistent lack of detectable HIV-1 antibody in a person with HIV infection - Utah, 1995. MMWR Morb Mortal Wkly Rep 1996;45:181-5.
8. Busch MP, Holland PV. Idiopathic CD4+ T-lymphocytope-nia (ICL) and the safety of blood transfusions: what do we know and what should we do? (editorial). Transfusion 1992;32:800-4.
9. Zuck TF, Thomson RA, Schreiber GB, et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995;35:944-51.
10. Sayre KR, Dodd RY, Tegtmeier G, et al. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors. Transfusion 1996;36:45-52.
11. Kleinman S, Busch MP, Hall L, et al. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retroirus Epidemiology Donor Study. JAMA 1998;280:1080-5.
12. Kleinman SH, Kaplan JE, Khabbaz RF, et al. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group. J Clin Microbiol 1994;32:603-7.
13. Busch MP, Tobler L, Quan S, et al. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors. Transfusion 1993;33:84-8.
14. Evans CS, Tobler L, Polito A, et al. Comparative evaluation of supplemental hepatitis C virus antibody test systems. Transfusion 1992;32:408-14.
15. Busch MP, Laycock M, Kleinman SH, et al. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Blood 1994;83:1143-8.
16. Kleinman S, Alter H, Busch M, et al. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion 1992;32:805-13.
17. Dhaliwal SK, Prescott LE, Dow BC, et al. Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol 1996;48:184-90.
18. Proficiency survey series. Waukegan, IL: College of American Pathologists, 1998 [published annually].
19. Kleinman SH, Niland JC, Azen SP, et al. Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository. Transfusion 1989;29:572-80.
20. Busch MP, Taylor PE, Lenes BA, et al. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group. N Engl J Med 1990;323:1308-12.
21. Linden JV, Kaplan HS. Transfusion errors: causes and effects. Transfus Med Rev 1994;8:169-83.